Calcium dynamics is central in cardiac physiology, as the key event leading to the excitation-contraction coupling (ECC) and relaxation processes. The primary function of Ca 2ϩ in the heart is the control of mechanical activity developed by the myofibril contractile apparatus. This key role of Ca 2ϩ signaling explains the subtle and critical control of important events of ECC and relaxation, such as Ca 2ϩ influx and SR Ca 2ϩ release and uptake. The multifunctional Ca 2ϩ -calmodulin-dependent protein kinase II (CaMKII) is a signaling molecule that regulates a diverse array of proteins involved not only in ECC and relaxation but also in cell death, transcriptional activation of hypertrophy, inflammation, and arrhythmias. CaMKII activity is triggered by an increase in intracellular Ca 2ϩ levels. This activity can be sustained, creating molecular memory after the decline in Ca 2ϩ concentration, by autophosphorylation of the enzyme, as well as by oxidation, glycosylation, and nitrosylation at different sites of the regulatory domain of the kinase. CaMKII activity is enhanced in several cardiac diseases, altering the signaling pathways by which CaMKII regulates the different fundamental proteins involved in functional and transcriptional cardiac processes. Dysregulation of these pathways constitutes a central mechanism of various cardiac disease phenomena, like apoptosis and necrosis during ischemia/reperfusion injury, digitalis exposure, post-acidosis and heart failure arrhythmias, or cardiac hypertrophy. Here we summarize significant aspects of the molecular physiology of CaMKII and provide a conceptual framework for understanding the role of the CaMKII cascade on Ca 2ϩ regulation and dysregulation in cardiac health and disease. Calcium signaling is central in cardiac physiology and the link of the different steps of excitation-contraction coupling (ECC) and relaxation mechanisms. Moreover, the multifunctional Ca 2ϩ -calmodulin-dependent protein kinase II (CaMKII) is a signaling molecule that regulates ECC in the heart but is also involved in several cardiac diseases. The present review proffers an outline of intracellular Ca 2ϩ handling in the heart, as well as on CaMKII localization, regulation, and targets in the cardiac myocyte. The review also focuses on Ca 2ϩ dysregulation and CaMKII activation in ischemia/reperfusion (I/ R), as well as the dual role of CaMKII in this condition (i.e., beneficial in the stunned heart, but detrimental in irreversible I/R injury, leading to apoptosis and necrosis). We also address the importance of ryanodine receptors (RyR2) and their regulation by CaMKII in different proarrhythmic processes, such as those occurring during reperfusion, after acidosis, atrial fibrillation, heart failure (HF), and digitalis intoxication. Finally, the role of CaMKII in cardiac transcriptional regulation is described. We hope that this review may help to provide a solid basis for understanding the importance of the CaMKII cascade in cardiac health and disease.
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Overview of Intracellular Ca 2ϩ Dynamics
Calcium is a remarkably ubiquitous and versatile intracellular signal, since not only does it trigger and regulate a number of physiological processes but also may play an important role in regulation of its own fluxes among cell organelle and plasma membranes. The primary function attributed to Ca 2ϩ in muscle cells is to control mechanical activity developed by the myofibril contractile apparatus. In the cardiac muscle, membrane depolarization during the action potential (AP) triggers a transient rise in cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) that leads to a phasic contraction. Thus Ca 2ϩ dynamics in the cytosol is the most critical event in the ECC process.
In the mature mammalian ventricular myocardium, most of the Ca 2ϩ that contributes to an AP-triggered Ca 2ϩ transient is released from the sarcoplasmic reticulum (SR) (27), upon binding of Ca 2ϩ to RyR2 (Fig. 1) , a mechanism identified as Ca 2ϩ -induced Ca 2ϩ release (38). These channels are homotetramers and are assembled in a macromolecular complex that includes RyR2 regulatory molecules, such as calmodulin (CaM), FK-506 binding proteins (FKBP12/12.6), and protein phosphatases and kinases, including CaMKII (64, 135, 144) . Thus Ca 2ϩ can regulate the channels by both, direct binding to them and via CaM and CaMKII. During the AP, Ca 2ϩ influx through voltage-dependent L-type Ca 2ϩ channels (LTCC) causes a rapid and large increase in subsarcolemmal [Ca 2ϩ ], which results in the synchronized opening of RyR2 clusters and massive Ca 2ϩ release to the dyadic space, from which Ca 2ϩ diffuses to the bulk cytosol and reaches the myofilaments (Fig. 1) . It is accepted that SR Ca 2ϩ release during ECC is terminated by closure of the RyR2, attributed to regulation of the channels by intra-SR local free [Ca 2ϩ ] and proteins directly or indirectly associated with RyR2, such as calsequestrin, triadin, and junctin (47, 59, 158) . Because the release is not sustained, the cytosolic Ca 2ϩ transient is self-limiting, since the rise in [Ca 2ϩ ] i not only activates contraction but also increases the transport rate of mechanisms that remove Ca 2ϩ from the cytosol, thus causing [Ca 2ϩ ] i to fall and mechanical relaxation to occur. Among these transporters, the most prominent is the SR Ca 2ϩ -ATPase (SERCA2a), located in the extra-dyadic SR, which allows refilling the SR Ca 2ϩ store (8, 89). SERCA2a is negatively regulated by phospholamban (PLN; Fig. 1 ). However, this inhibition may be relieved by PLN phosphorylation, which decreases the PLN-SERCA interaction (29, 61) . Moreover, the effects of PLN on cardiac function are subjected to additional regulation by its interacting partners (61) . The most important Ca 2ϩ efflux mechanism is the Na ϩ -Ca 2ϩ exchanger (NCX), which, at steady-state cyclic activity, removes most of the Ca 2ϩ that enters the cell during the AP (27, 33), whereas slower mechanisms (the sarcolemmal Ca 2ϩ -ATPase and mitochondrial Ca 2ϩ influx pathways) do not seem to play a significant role in the decline of electrically triggered Ca 2ϩ transients in the mature myocardium (7, 19) . Because the SR is the major Ca 2ϩ source for ECC, it is plausible to consider that contraction amplitude largely depends on how much Ca 2ϩ is released from it. During a twitch, this organelle releases only a fraction (50 -70%) of its total content (6, 10, 117, 118 
CaMKII Structure, Function, and Targets
Molecular physiology and localization. CaMKII is a multimeric holoenzyme complex consisting of a pair of hexameric assembled rings ( Fig. 2A) . There are four CaMKII gene products: ␣, ␤, ␥, ␦ (52). These genes show differential tissue expression, with CaMKII␦ being the predominant isoform in the heart (32), although CaMKII␥ is also present (120) . In the adult myocardium, two major splice variants of CaMKII␦ are expressed: CaMKII␦ B and CaMKII␦ C (32). CaMKII␦ B possesses an 11-amino acid nuclear localization signal that is responsible for its preferential nuclear localization, whereas the splice variant ␦ C (lacking only this 11-amino acid nuclear localization signal) is preferentially localized in the cytosol (122) . It is also well known that most CaMKII isoforms readily form stable hetero-oligomers, such that the ratio of ␦ B to ␦ C in a multimer could regulate the localization of the holoenzyme (100, 122) . However, even when only one splice variant (CaMKII␦ B or CaMKII␦ C ) is expressed, CaMKII␦ B is not exclusively nuclear and CaMKII␦ C is not exclusively cytosolic. Interestingly, the relative expression of CaMKII␦ B can be altered in vitro by phosphorylation/dephosphorylation processes and has been shown to be modified under different physiological and pathological conditions, suggesting that CaMKII␦ splicing is a highly regulated dynamic process (44). Indeed, recent experimental evidence suggests that CaMKII␦ splice variants are selectively susceptible to autophosphorylation/oxidation, providing CaMKII with a mechanism for target signaling specificity (12).
Mechanisms of CaMKII activation and regulation. As shown in Fig. 2A (93) . Indeed, activation of the renin-angiotensin-aldosterone signaling pathway, which promotes enhanced oxidative stress in the heart (87), induces CaMKII-dependent apoptosis of cardiac myocytes in the absence of significant increases in cytosolic Ca 2ϩ in vitro (93) and in vivo (136) . Moreover, apoptosis induced by the hormone is prevented in isolated neonatal mouse myocytes expressing the oxidation-resistant mutant CaMKII (35). Similarly, in the prediabetic stage induced in a model of impaired glucose tolerance, it has been described that the increase in oxidative stress contributed to CaMKII activation, SR Ca 2ϩ leak, and the generation of arrhythmias and apoptosis (94, 121) . These findings suggest that conditions of high ROS production may lead to increased CaMKII activity, even in the absence of changes in the basal levels of Ca 2ϩ /CaM. Interestingly, recent experiments have described that ROS production may also occur downstream CaMKII activation (92, 116) . These experiments suggest that under conditions of high oxidative stress, a vicious cycle of CaMKII activation and ROS production may occur. Further experimental evidence is required to confirm this possibility.
Two additional posttranslational modifications of CaMKII have been recently reported. Erickson et al. (36) described, using overt diabetes cellular and animal models, a novel mechanism for CaMKII activation during hyperglycemia, different from that produced by the oxidation of CaMKII, typical of diabetic patients (71) . This mechanism occurs through the addition of an O-linked N-acetylglucosamine (O-GlcNAc) at the Ser 280 site, which similarly to oxidation and phosphorylation, creates molecular memory after the decline in Ca 2ϩ concentration. It has also been shown that nitric oxide production by ␤-adrenergic stimulation is sufficient, by itself, to activate CaMKII and increase SR Ca 2ϩ leak, leading to arrhythmogenic spontaneous Ca 2ϩ waves (22, 46, 56). Zhang et al. (153) further showed that nitric oxide-PKG signaling augmented CaMKII activity in rabbit ventricular myocytes. Moreover, in vitro studies showed that CaMKII contains S-nitrosylated cysteine residues, and computational prediction of Snitrosylation sites on CaMKII indicates different potential target sites, including the Cys 290 site in the CaMKII␦ regulatory domain (46). Coultrap and Bayer (21) recently demonstrated that nitrosylation of CaMKII␣ at the analogous Cys 289 and also Cys 280 (Met 281 in CaMKII␦) sites was critical to autonomous CaMKII activation by nitric oxide donors. The cluster of the different regulatory sites at the regulatory/autoinhibitory CaMKII-domain suggests that these sites are part of a hotspot region for post-translational regulation of the kinase.
CaMKII targets in the heart. CaMKII regulates different ion channels and transport proteins involved in cardiac ECC (Fig.  2B ). CaMKII-dependent phosphorylation of LTCC potentiates I CaL and slows its inactivation (152) . Experimental evidence indicates that, in the long term, both ␦ B and ␦ C CaMKII isoforms decrease the expression of LTCC pore-forming ␣1c-subunit (101). CaMKII-dependent phosphorylation of PLN increases SR Ca 2ϩ uptake, whereas phosphorylation of RyR2 increases diastolic SR Ca 2ϩ leak and systolic SR Ca 2ϩ release (25, 40, 43, 45, 108, 134, 145) . CaMKII also catalyzes phosphorylation of the Na ϩ -H ϩ exchanger (NHE-1) (139), and of the voltage-gated ion channels responsible for Na ϩ current (I Na ), transient outward K ϩ current (I to ), and inward rectifier K ϩ current (I K1 ) (67, 142, 143) . Persistent (late) inward Na ϩ current (I NaL ) is enhanced (gain-of-function effect). In contrast, Na ϩ channel availability is reduced, intermediate inactivation 
is enhanced, and recovery from inactivation of rapid I Na is slowed by CaMKII-dependent phosphorylation (loss-of-function effects) (142) . The effects of CaMKII on I to and I K1 are complex (67, 143) . Acute and chronic CaMKII overexpression increases I to , slow amplitude and expression of the underlying channel protein K V1. 4 . On the other hand, chronic but not acute CaMKII overexpression causes downregulation of I to,fast , as well as of K V4.2 and KChIP2. Interestingly, these amplitude changes were not reversed by acute CaMKII inhibition, consistent with CaMKII-dependent regulation of channel expression and/or trafficking (143) . It has also been shown that the overexpression of CaMKII␦ B led to an increase in NCX abundance and disruption of the NCX/SERCA2 expression balance via class IIa histone deacetylase (HDACs)/myocyte enhancer factor-2 (MEF2)-dependent signaling (70) . Moreover, available data indicates that NCX upregulation induced by ␤-adrenoceptor stimulation is dependent on CaMKII activation in the adult heart (72) .
Further work demonstrated that CaMKII interacts with the mitochondrial Ca 2ϩ uniporter (MCU) and promotes Ca 2ϩ entry into the mitochondria, probably by catalyzing phosphorylation of serine residues 57 and 92 (57 (73, 80, 103, 132) . This increase has been related to a diversity of concurrently altered Na ϩ -dependent (55, 85, 99, 128, 129) and independent mechanisms (88, 123, 125) . The core of these changes essentially lies on the oxygen deprivation produced by blood flow reduction and the consequent shift from aerobic to anaerobic metabolism (86) . Fluorescent detection of cytosolic and SR Ca 2ϩ transients at the epicardial layer of the intact beating heart (78) demonstrated (132) (Fig. 3B) . More recent experiments further showed that a major mechanism for the increase in diastolic [Ca 2ϩ ] i during ischemia is an increase in the frequency of Ca 2ϩ sparks. Notably, the increase in Ca 2ϩ sparks during ischemia switched to an increase in arrhythmogenic Ca 2ϩ waves during reperfusion (74) (Fig. 4) .
Activation of CaMKII in I/R. Previous studies showed the time course of phosphorylation of Thr 17 of PLN, used as a marker of CaMKII activation, during I/R. This initial work showed a significant increase in Thr 17 phosphorylation at the beginning of ischemia and at the onset of reflow (141) . Experimental evidence reveals that Ca 2ϩ influx through LTCC and phosphatase inhibition, due to the ischemia-induced intracellular acidosis, play a central role in the activation of CaMKII at the beginning of ischemia (83, 84) .
The increase in Thr 17 phosphorylation at the onset of reperfusion may be produced by the transient increase in cytosolic [Ca 2ϩ ] that occurs at this time (86) . This [Ca 2ϩ ] i increase has been usually attributed to the influx of Ca 2ϩ through the reverse mode of the NCX (54, 86, 95) . However, the abrupt Ca 2ϩ release from the SR recently described at the onset of reperfusion (132) may also be greatly involved in the increase in CaMKII activation and PLN Thr 17 phosphorylation at this moment.
Reperfusion is also associated with ROS generation (15). As described earlier in this review, both Ca 2ϩ mishandling and ROS production set an ideal intracellular milieu for activation of CaMKII. Further studies have shown that other CaMKII substrates are also phosphorylated at the beginning of reperfusion, e.g., the Ser 2814 site of RyR2, which have been shown to play a significant role in reperfusion injury (28, 108), as it will be discussed next. 
Dual role of CaMKII in I/R.
In the last few years, a dual effect of CaMKII-dependent protein phosphorylation (beneficial and detrimental) has been described in the scenario of I/R in the intact heart. The beneficial effect of CaMKII refers to the recovery of intracellular Ca 2ϩ and contractile function that occurs during stunning (109, 133) , a fully reversible postischemic dysfunction (20). It has been shown that phosphorylation of PLN-Thr 17 is essential for the recovery of Ca 2ϩ transients and contractility in the stunned heart (109, 133) , offering a mechanism that helps to limit cytosolic Ca 2ϩ overload, by accelerating SR Ca 2ϩ reuptake and ameliorating intracellular Ca 2ϩ handling. The detrimental effect of CaMKII refers to the role of CaMKII in reperfusion arrhythmias, which occur even after a short ischemic period (11, 108), and to the necrosis and apoptosis typical of the irreversible I/R injury (28, 110, 140). Targeted inhibition of CaMKII at the level of cardiac SRmembranes in mice (SR-AIP) clearly indicated that most of reperfusion arrhythmias are triggered by CaMKII-dependent mechanisms (108) . Moreover, prevention of CaMKII-dependent phosphorylation of RyR2 was able to significantly reduce reperfusion arrhythmias (108) , but failed to completely prevent them. These findings indicate that other CaMKII targets may be involved in reperfusion arrhythmias. A possible candidate is Thr 17 of PLN, which is phosphorylated at the beginning of reperfusion in association with the increase in CaMKII phosphorylation of Ser 2814 of RyR2 (108) . Phosphorylation of Thr 17 and the consequent increase in SR Ca 2ϩ reuptake could produce two opposite effects, which are actually inherent to the characteristics of SR Ca 2ϩ uptake itself. On one hand, increasing SERCA2a activity would increase the rate of resequestration of the Ca 2ϩ released through RyR2. This would reduce cytosolic Ca 2ϩ levels, increasing the availability of free cytosolic buffer sites able to bind Ca 2ϩ (increase in dynamic cytosolic buffer capacity). This may limit Ca 2ϩ wave propagation and reperfusion arrhythmias (4, 53) . On the other hand, increasing Ca 2ϩ sequestration would necessarily increase SR Ca 2ϩ content, favoring diastolic Ca 2ϩ leak. This situation would be exacerbated if the increase in SR Ca 2ϩ uptake coexists with an increase in the open probability of RyR2, as that produced by CaMKII-dependent phosphorylation (134) , and may contribute to favor a futile circle of increased SR Ca 2ϩ uptake and leak with an additional metabolic cost. Thus the beneficial effects of the increase in SR Ca 2ϩ uptake in I/R may turn to be deleterious under conditions in which the balance between SR Ca 2ϩ uptake and leak is lost. Finally, although in the experiments in SR-AIP mice with inhibition of CaMKII targeted to the SR, reperfusion arrhythmias virtually disappeared, phosphorylation of LTCC by CaMKII was also inhibited in these mice (98) . Thus the contribution of CaMKIIdependent LTCC phosphorylation to reperfusion arrhythmias cannot be excluded.
After a prolonged ischemic period, reperfusion evokes irreversible cardiac injury. Under these conditions, myocytes die by apoptosis, autophagy, and necrosis. Experimental evidence indicates that CaMKII inhibition is protective in the irreversible I/R injury (28, 110, 140, 154) . Although the mechanisms of this protection are still unclear, it has been established that CaMKII is clearly involved in the intrinsic (mitochondrial) cell death pathway (110) . This signaling pathway involves CaM-KII-dependent phosphorylation of SR protein(s), mitochondrial Ca 2ϩ overload, cytochrome c release, and caspase-3 activation (28, 110, 140) . Notably, this cascade of events mediates not only the programmed cell death known as apoptosis but also a CaMKII-dependent programmed necrosis (110) . These deleterious effects appear to be associated with both RyR2 phosphorylation and caspase-mediated degradation of this protein, which in turn would favor an increase in SR Ca 2ϩ leak. Supporting and extending the signaling cascade described, Joiner et al. (57) showed that CaMKII-dependent phosphorylation of MCU increases Ca 2ϩ entry through it and favors cell death.
Phosphorylation of Thr 17 , the CaMKII site of PLN, was also transiently enhanced at the onset of reperfusion (110, 140) . However, the functional consequences of PLN phosphorylation and of the increase in SR Ca 2ϩ uptake after prolonged ischemia are controversial and remain uncertain (90, 126, 127, 151 16 and Thr 17 mutated to Ala), submitted to I/R. In these mice, cardiac damage was significantly enhanced, suggesting that increasing Thr 17 phosphorylation to the level observed at the onset of reperfusion (when phosphorylation of Ser 16 did not occur) has protective effects. However, when CaMKII-dependent RyR2 phosphorylation was selectively precluded, prevention of PLN phosphorylation failed to increase cardiac injury. Thus the results from Di Carlo et al. (28) strongly suggest that CaMKII-dependent inhibition of RyR2 phosphorylation is necessary and sufficient to prevent CaMKII-dependent cardiac damage that originates at the SR level in I/R. Taken together, these findings indicate that the progression toward a beneficial or detrimental effect of CaMKII activation and PLN phosphorylation in I/R would critically depend on the balance between the extent of SR Ca 2ϩ reuptake and the SR Ca 2ϩ leak, largely given by the status/characteristics of other proteins also involved in SR Ca 2ϩ handling, such as RyR2.
CaMKII, Ryanodine Receptors, and Arrhythmias
CaMKII has been shown to contribute to arrhythmogenesis in cardiac pathologies of different etiology. Although CaMKIIdependent arrhythmogenesis was originally attributed to its impact on sarcolemmal LTCC and the development of early afterdepolarizations, which may indeed occur (1), intense ongoing investigation has provided evidence of multiple additional targets through which CaMKII may exert its arrhythmogenic action. Among these, RyR2 seem to be one of particular functional importance. A CaMKII-dependent increase in RyR2 open probability has been shown to increase SR Ca 2ϩ leak, which would enhance Ca 2ϩ extrusion via the electrogenic NCX. This electrogenic transport generates a depolarizing current (I ti or transient inward current) (34, 114), which, when sufficiently large, leads to delayed afterdepolarizations (DADs), that may reach the threshold and trigger spontaneous AP, resulting in extra-systoles and ventricular arrhythmias (146) (Fig. 5) content is driven up (e.g., by heart rate, sympathetic activation, or post-ischemic Ca 2ϩ overload), the propensity for triggering SR Ca 2ϩ sparks and waves leading to DADs and arrhythmias can be dramatically increased.
In addition to phosphorylation, RyR2 function may be enhanced by oxidation at the level of specific methionine residues (16, 130). RyR2 contains multiple thiols (150) that can be affected by redox modification. RyR2 thiol oxidation increases the sensitivity of the channel to luminal Ca 2ϩ , thus lowering the critical SR Ca 2ϩ content at which spontaneous Ca 2ϩ release occurs (130) . As mentioned above, CaMKII can also be activated by oxidation. In addition, recent data suggests that CaMKII can enhance ROS production (116) . Thus CaMKII may promote arrhythmogenic RyR2 Ca 2ϩ leak not only by enhancing RyR2 phosphorylation but also by promoting its oxidation. Consistent with this, Ho et al. (51) showed that arrhythmogenic adverse effects of cardiac glycosides involve alterations in RyR2 function caused by oxidative changes in the channel structure. More recently, Gonano and Vila Petroff (42) demonstrated that cardiac glycoside-induced arrhythmias require CaMKII activation, suggesting that CaMKII-dependent RyR2 oxidation could also participate in the development of the arrhythmogenic substrate. Although the relevance of CaMKIIdependent oxidation of RyR2 remains to be further explored, experiments in knock-in mice in which the site Ser 2814 of the RyR2 could not be phosphorylated (S2814A mice) provided unequivocal evidence of the importance of phosphorylation of this site in cardiac glycoside-induced arrhythmias (50) . Myocytes isolated from S2814A mice did not show enhanced SR Ca 2ϩ leak when exposed to digitoxin, compared with myocytes from wild-type mice. These experiments demonstrate that phosphorylation, rather than oxidation of RyR2, is required for the increase in channel spontaneous activity and arrhythmogenesis in the context of digitalis toxicity.
CaMKII has also been shown to be involved in cardiac arrhythmias associated with acidosis. This is important in the clinical setting since substantial changes in pH may occur in disorders of different origin, such as sleep apnea/hypopnea syndrome, diabetic ketoacidosis, or during episodes of myocardial ischemia. Said et al. (107) showed that ectopic activity produced upon returning to normal pH after acidosis could be prevented by pharmacologic inhibition of CaMKII and did not occur in a transgenic mouse model with the inhibition of CaMKII targeted to the SR. The authors concluded that CaMKII activation during acidosis favors an increase in SR Ca 2ϩ load by phosphorylation of PLN Thr 17 , which, on the one hand, is responsible for the mechanical recovery observed with sustained acidosis, but may also increase spontaneous SR Ca 2ϩ leak and produce arrhythmias during the return to normal pH. This effect was attributed to the increase in the opening probability of RyR2 due to the pH increase after acidosis and the acidosis-induced increase in SR Ca 2ϩ content, still present at the beginning of post-acidosis period. The return to normal pH also leads to recovery of the acidosis-induced inhibition of NCX (97), favoring Ca 2ϩ extrusion and Na ϩ gain into the cell, membrane depolarization, and eventually triggered arrhythmias. Together, these results indicate that post-acidosis CaMKIIdependent DADs are triggered by two concurrent factors: 1) acidosis-induced increase in SR Ca 2ϩ content and 2) relief of acidosis-induced inhibition of RyR2 and NCX.
The evidence provided herein demonstrates the critical role played by CaMKII and RyR2 in arrhythmogenesis and suggests the potential therapeutic benefit of CaMKII inhibition for the treatment of arrhythmias. However, the ubiquitous nature of CaMKII and its effects on different protein targets challenge the use of CaMKII inhibitors as a therapeutic tool. Moreover, pharmacological CaMKII inhibition would probably require compounds selective toward cardiac-specific CaMKII isoforms, which are not currently available. In addition, a targetspecific therapy would be desirable, taking into account the existence of multiple targets for CaMKII activity. For example, the phosphorylation of the PLN site Thr 17 plays a key role in the ␤-adrenergic inotropic response and mediates the recovery of contractility after cardiac acidosis (107) .
The demonstration of RyR2 as a crucial player in the development of CaMKII-induced arrhythmias allows us to postulate an alternative therapeutic approach, which involves the concept of RyR2 stabilization. The term "stabilization" refers to the possibility to reduce RyR2 spontaneous diastolic opening without affecting systolic release. Thus compounds that are able to stabilize the RyR2 could be used to prevent arrhythmias without the undesirable effects of global CaMKII inhibition. Indeed, using the multi-channel blocker JTV-519 (K201), which has been shown to stabilize the RyR2, Sacherer et al. (104) showed, in mouse myocytes and in nonfailing human myocardium treated with the cardiac glycoside ouabain, that JTV-519 was able to reduce the ouabain-induced SR Ca 2ϩ leak. Similarly, additional reports showed that alternative RyR2 stabilizers such as VKII86 or tetracaine could reduce DAD-triggered arrhythmias (137, 156) . Further work is warranted to find the ideal RyR2 stabilizer, which should reduce spontaneous RyR2 openings during diastole without inhibition of the normal Ca 2ϩ -induced Ca 2ϩ release that triggers contraction. This is the case for dantrolene (75) , although dantrolene is now only used for acute treatment of malignant hyperthermia. Nevertheless, novel RyR2 stabilizers could be a promising approach for the treatment of arrhythmias of different etiology.
CaMKII in cardiac transcriptional regulation. The foregoing discussion has focused on acute modulatory effects of CaMKII on ion channels, transporters, and myofilaments, but activation of CaMKII can also have major effects on gene transcription. This should be considered as a slower response to certain stress-related signals in which the acute regulatory CaMKII-dependent effects may not be sufficient. This type of transcriptional regulation can be beneficial but can also contribute to maladaptive signals in hypertrophy and HF. Indeed, when myocyte CaMKII is chronically activated, as in all of the above autonomous states (autophosphorylation, oxidation, OGlcNAcylation, nitrosylation), it appears to be largely maladaptive by worsening arrhythmogenic diastolic SR Ca 2ϩ leak and altering expression and gating of ion channels in ways that contribute to arrhythmogenesis. Moreover, this situation seems to occur in HF or upon CaMKII overexpression (either genetically induced or as an intrinsic part of the hypertrophy/HF phenotype). Thus both acute and transcriptional actions of CaMKII can contribute to acute dysfunctions of the type discussed above. Ca 2ϩ -dependent signaling can lead to transcriptional regulation, and we call this process excitation-transcription-coupling (ETC), by analogy to ECC. One ETC pathway that is known to directly involve CaMKII is the CaMKII-dependent phosphorylation of class II histone deacetylases, HDACs, of which HDAC4 and HDAC5 have been the best studied (3, 77, 96, 149) . As illustrated in Fig. 6 , at baseline when these HDACs are dephosphorylated, they bind to and repress hypertrophic transcription factors, such as myocyte enhancer factor 2 (MEF2). Although these particular HDACs have weak histone deacetylase activity, their presence at MEF2 also prevents histone acetyl transferase localization, resulting in more condensed de-acetylated chromatin structure in this situation. When these HDACs are phosphorylated by CaMKII or protein kinase D (PKD), translocation out of the nucleus via binding to 14-3-3 chaperone proteins is induced. This translocation relieves MEF2 repression, allows histone acetyl transferase binding, and favors transcriptional activation (Fig. 6) . We focus here on the upstream side of these ETC pathways.
Calcineurin (CaN) is an additional Ca 2ϩ -dependent ETC pathway that works in parallel with the CaMKII-HDAC pathway (Fig. 6) (62, 81, 147 ). When the phosphatase CaN is activated by Ca-CaM, it dephosphorylates nuclear factor of activated T cells (NFAT), and dephosphorylated NFAT is translocated to the nucleus where it interacts with transcription factors (e.g., GATA4) and activates the transcription of genes involved in hypertrophic signaling and HF. So, two questions that come up are where CaN and CaMKII are localized with respect to ETC and whether the same types of Ca-CaM signals are likely to drive these two Ca-CaM-dependent ETC pathways.
Regarding subcellular localization, at baseline in adult ventricular myocytes, both CaN and CaMKII seem to be preferentially concentrated at the Z-line, at or near the SR T-tubule junctions involved in ECC (but also exist elsewhere). This localization has four important implications. First, if one measures global CaN or CaMKII activation state, it may be biased by the quantitatively large amount of CaN and CaMKII at these sites. Second, the local [Ca 2ϩ ] i in this junctional cleft domain is very different from the global or nuclear [Ca 2ϩ ] i , because of the close proximity to both L-type Ca 2ϩ channels and RyR2 channels (i.e., peak and even diastolic [Ca 2ϩ ] i here can be much higher than anywhere else in the myocyte). Third, there may be significant translocation of CaN or CaMKII or their downstream targets (e.g., NFAT or HDAC), that could allow Ca 2ϩ -dependent signaling in this ECC domain to have longer distance effects on ETC. Fourth, CaN and CaMKII in different subcellular domains (cleft, perinuclear, intranuclear) may have more selective and locally dictated signaling to the ETC machinery. This will be discussed further below.
CaN and CaMKII have very different Ca-CaM affinities, which may be very important functionally. CaMKII has a relatively low Ca-CaM affinity (K d ϭ 10 -50 nM), whereas CaN has a very high Ca-CaM affinity (K d Ͻ Ͻ1 nM) (112, 113) . CaMKII activation requires relatively high local [Ca 2ϩ ] i and will tend to de-activate more rapidly when [Ca 2ϩ ] i declines. Thus CaMKII activation works especially well in environments where large local Ca 2ϩ transients occur, such as near the mouths of Ca 2ϩ channels. One place that this occurs is in the ECC cleft near L-type Ca 2ϩ channels and RyR2, and this environment is expected to be more sensitive to CaMKII activation (31). A second location is at the nuclear envelope, where the 1,4,5-inositol-trisphosphate (InsP 3 ) receptor (InsP 3 R) type 2 (the main isoform in adult ventricular myocytes) is concentrated. Both CaM and CaMKII appear to directly associate with the InsP 3 R (5). Thus Ca 2ϩ released by the nuclear envelope InsP 3 R can cause a high local [Ca 2ϩ ] i that is sufficient to activate CaMKII. That activated nuclear CaM-KII can then phosphorylate the InsP 3 R and inhibit channel gating, constituting a local negative feedback loop that may limit the duration of local InsP 3 R Ca 2ϩ release. However, this local CaMKII activation may also be critical for CaMKIIdependent nuclear signaling to HDACs in ETC (149) . Note also that CaMKII activation has memory in the form of autonomous activation; that is, if local [Ca 2ϩ ] i is sufficiently high for a long enough time, there is much greater likelihood for a neighboring CaMKII monomer in the dodecameric structure to become autophosphorylated, oxidized, O-GlcNAcylated, or nitrosylated, all of which would prolong the active autonomous state. The other side of this issue is that bulk cytosolic CaMKII (e.g., near PLN or myofilament sites) may not be substantially activated during beat to beat global Ca 2ϩ transients (112) . So it is less clear how CaMKII that is not near Ca 2ϩ channels is normally activated. CaN activation is very different from that of CaMKII, because of its very high Ca-CaM affinity and slow off-rate (112) . CaN that is very near Ca 2ϩ channels that open at each beat (e.g., SR-T-tubule clefts) could be nearly fully activated at each beat, and the slow deactivation could result in nearly fully activated local CaN at all relevant heart rates. In contrast, cytosolic CaN that is far away from Ca 2ϩ channels could still be activated in a way that is intrinsically integrating because of the slow off-rate of Ca-CaM; that is, each Ca 2ϩ transient would slightly increase the CaM-CaN level, but the slow off-rate would mean that it does not relax back before the next Ca 2ϩ pulse drives a bit more CaM onto CaN. So both CaN and CaMKII exhibit molecular memory, but the molecular basis differs considerably.
Olson's laboratory was the first to demonstrate both the important role of class II HDACs in cardiac ETC, as well as the fact that CaMKII can be an HDAC kinase (3, 96) . Indeed, both HDAC4 and 5 in cardiac myocytes are phosphorylated by CaMKII and PKD (which is another member of the CaMK kinome family). That HDAC phosphorylation induced HDAC nuclear export, and that could be induced by neurohumoral stimuli [e.g., by endothelin-1 (ET-1) and ␣-adrenergic activation by phenylephrine (PE)], that are known to be parts of the hypertrophic signaling pathway, and also the neurohumoral storm associated with the vicious cycle of HF. The HDAC4 protein contains a specific CaMKII docking, since that CaMKII activation is very tightly linked to HDAC4 nuclear export.
HDAC5 knockout mice exhibit baseline cardiac hypertrophy and have an exaggerated hypertrophic response to pressure overload or cardiac CaN activation (24), suggesting that HDAC5 might be a particularly important ETC pathway in mammalian heart. HDAC5 does not have the CaMKII docking site as in HDAC4, and in HEK cells or cultured neonatal myocytes, HDAC5 nuclear export is controlled by PKD rather than CaMKII. However, in adult ventricular myocytes, where PKD expression is dramatically lower than in the neonate (48), and where CaMKII expression is higher, CaMKII and PKD appear to be equal partners in HDAC5 phosphorylation, nuclear export, and MEF2 driven transcription in response to ET-1 (149) . Moreover, ET-1-induced HDAC5 nuclear export was entirely dependent on Ca 2ϩ release through InsP 3 R type 2 at the nuclear envelope, since it was abolished in InsP 3 R2 knockout mice or by InsP 3 R inhibitors, and could be quantitatively mimicked by selective InsP 3 R activation in adult ventricular myocytes (149) . HDAC5 translocation driven by the ␣-adrenergic agonist PE is like that induced by ET-1 at the endothelin receptor in that it is mediated by the G-protein G aq (17) . Surprisingly, PE-induced HDAC5 nuclear export was completely independent of Ca 2ϩ , InsP 3 R, or CaMKII activity and instead was completely dependent on PKC-and PKDdependent signaling (note that PKC did not seem to be important in ET-1-induced HDAC5 nuclear export). Bossuyt et al. (17) used confocal, targeted fluorescence resonance energy transfer (FRET)-based reporters and total internal reflectance fluorescence (TIRF) microscopy to elucidate the mechanism for this ET-1 versus PE difference. For PE activation, PKD was rapidly recruited and activated at the sarcolemma, but then it was very rapidly translocated to the nucleus, where it could phosphorylate HDAC5. For ET-1, PKD was also rapidly recruited to the sarcolemma where it was activated, but in this case, PKD largely remained at the sarcolemma and did not shuttle to the nucleus. So although PKD can powerfully drive HDAC5 nuclear export, it depends on how PKD is activated. For ET-1, which activates CaMKII via an InsP 3 -dependent nuclear pathway but activates PKD preferentially at the sarcolemma, nuclear HDAC5 is substantially CaMKII dependent.
During stress, there is often co-activation of the G q -coupled receptors (ET-1 and ␣-adrenergic) with ␤-adrenergic receptors (␤-AR). Chang et al. (23) evaluated this cross-talk in adult ventricular myocytes. ␤-AR activation caused an acute PKAdependent HDAC5 nuclear import that was mediated by PKAdependent phosphorylation of HDAC5 at Ser 279 , between the two PKD/CaMKII sites (Ser 259 and Ser 498 ), which are responsible for driving ET-1 and PE-induced HDAC5 nuclear export. This effect could be mimicked by pseudo-phosphorylation of HDAC5 (S279D) and prevented by a nonphosphorylatable S279A mutant HDAC5. Moreover, this ␤-AR effect was dominant over the G q -coupled receptor effect in that the ET-1 or PE-induced nuclear export was blocked in the S279D HDAC5 mutant or after pretreatment of myocytes with isoproterenol or forskolin. However, chronic ␤-AR activation (over 24 h) allowed the usual ET-1 and PE effects to occur. Thus acute ␤-AR activation may suppress genetic reprogramming driven by this HDAC5 system during the acute fight-or-flight response. However, in chronic activation, as in HF, this ␤-ARinduced suppression may be overcome, such that the Gqcoupled signaling drives chronic HDAC5 nuclear export and activation of transcription, which reinforce the genetic HF phenotype (18).
In conclusion, CaMKII signaling in ETC is complex, and much additional work will be needed to fully understand the overall integrated Ca-CaM dependent signaling, even by just the CaMKII-HDAC and CaN-NFAT pathways discussed here. But these longer term ETC effects, which can change the expression levels of numerous ion channels and transporters as well as modulate their acute functional behavior in ECC, have to be integrated in the long run. 
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